Human papillomavirus is responsible for common condyloma acuminata and a number of
premalignant and malignant anogenital lesions. The immunocompromised population is at
particular risk because of a higher incidence of malignant transformation. Lesions in this
population may prove refractory to standard treatment. This is part II of a two-part review that
will discuss the treatment of condyloma acuminata and vaginal, vulvar, penile, and anal
intraepithelial neoplasias. This article will provide an updated review of available treatments …